MARK G FOLETTA Insider Trading
Get free email notifications about insider trading for MARK G FOLETTA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G FOLETTA. MARK G FOLETTA is a Senior VP, Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and a Sr VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and a SVP Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and a SVP, Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and a VP & Chief Financial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and a VP Finance & CFO in AMYLIN PHARMACEUTICALS INC ($AMLN) and a Director in AMN HEALTHCARE SERVICES INC ($AHS) and a Director in DEXCOM INC ($DXCM) and a Director in ENANTA PHARMACEUTICALS INC ($ENTA) and a Interim CFO in BIOCEPT INC ($BIOC) and a EVP & Chief Financial Officer in Tocagen Inc ($TOCA) and a Director in Regulus Therapeutics Inc. ($RGLS).
Address: 9360 TOWNE CENTRE DR SAN DIEGO 92121 CA
Companies in which MARK G FOLETTA is an Insider
AMN HEALTHCARE SERVICES INC
Industry: SERVICES-HELP SUPPLY SERVICES [7363]
Position of MARK G FOLETTA: Director
Holdings: 14,776 shares
Latest Transaction: Apr 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: SVP, Chief Financial Officer, SVP Chief Financial Officer, Sr VP Finance & CFO, Senior VP, Finance & CFO, VP Finance & CFO, VP & Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Aug 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCEPT INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of MARK G FOLETTA: Interim CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 02 2015
$BIOC Market Capitalization: $29.57M
$BIOC Previous Close: $1.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DEXCOM INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MARK G FOLETTA: Director
Holdings: 15,160 shares
Current Value: $1,207,797
Latest Transaction: Oct 19 2020
$DXCM Market Capitalization: $6.75B
$DXCM Previous Close: $79.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ENANTA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 04 2021
$ENTA Market Capitalization: $593.41M
$ENTA Previous Close: $32.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Forte Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: EVP & Chief Financial Officer
Holdings: 15,042 shares
Latest Transaction: Oct 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G FOLETTA: Director
Holdings: 81,910 shares
Current Value: $114,674
Latest Transaction: Dec 06 2017
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK G FOLETTA
Sentiment: All, AHS, AMLN, BIOC, DXCM, ENTA, TOCA, RGLS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 2021 | AHS | AMN HEALTHCARE SER ... | FOLETTA MARK G | Director | Option Exercise | A | 0.00 | 2,139 | 0 | 2,139 | |
| Apr 23 2021 | AHS | AMN HEALTHCARE SER ... | FOLETTA MARK G | Director | Option Exercise | M | 0.00 | 2,826 | 0 | 0 | |
| Apr 23 2021 | AHS | AMN HEALTHCARE SER ... | FOLETTA MARK G | Director | Buy | M | 0.00 | 2,826 | 0 | 14,776 | 12 K to 14.8 K (+23.65 %) |
| Mar 04 2021 | ENTA | ENANTA PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 49.92 | 7,500 | 374,400 | 7,500 | |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 398.25 | 208 | 82,835 | 14,202 | 14.4 K to 14.2 K (-1.44 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 397.41 | 375 | 149,030 | 14,410 | 14.8 K to 14.4 K (-2.54 %) |
| Oct 19 2020 | DXCM | DEXCOM INC | FOLETTA MARK G | Director | Sell | S | 396.51 | 255 | 101,109 | 14,785 | 15 K to 14.8 K (-1.70 %) |